Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Feldman

Showing results (821-830 of 921) with videos related to

Pageof 93
Sort By:
Leukemia Research|August 19, 2003
Phase II study of troxacitabine, a novel dioxolane nucleoside analog, in patients with untreated or imatinib mesylate-resistant chronic myelogenous leukemia in blastic phaseFrancis J Giles, Eric J Feldman, Gail J Roboz, et al.
JID Innovations : Skin Science From Molecules to Population Health|February 13, 2025
Exploring Pruritus in Bullous Pemphigoid: Analysis of QOL Metrics and Potential Biological MechanismsOlive C Osuoji, Taryn DeGrazia, Robin Rolader, et al.
Anatomical Sciences Education|January 9, 2023
Needs assessment of essential anatomy: The perspective of adult primary care resident physiciansMark H Hankin, Derek J Harmon, James R Martindale, et al.
Journal of Neurointerventional Surgery|February 9, 2021
Association of asymptomatic hemorrhage after endovascular stroke treatment with outcomesMichael J Feldman, Steven Roth, Matthew R Fusco, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2006
Phase I/II study of continuous-infusion troxacitabine in refractory acute myeloid leukemiaGail J Roboz, Francis J Giles, Ellen K Ritchie, et al.
Cancer Chemotherapy and Pharmacology|August 17, 2013
Clinical and laboratory studies of the novel cyclin-dependent kinase inhibitor dinaciclib (SCH 727965) in acute leukemiasIvana Gojo, Mariola Sadowska, Alison Walker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2006
Phase I study of bryostatin 1 and fludarabine in patients with chronic lymphocytic leukemia and indolent (non-Hodgkin's) lymphomaJohn D Roberts, Mitchell R Smith, Eric J Feldman, et al.
Inflammatory Bowel Diseases|May 19, 2015
Combined Immunosuppression Impairs Immunogenicity to Tetanus and Pertussis Vaccination Among Patients with Inflammatory Bowel DiseaseSeper Dezfoli, Henry A Horton, Nattapaun Thepyasuwan, et al.
Transplantation and Cellular Therapy|February 28, 2024
Improving Unrelated Donor Equity: Assessing Mismatched Donor Opportunities with Real-World Data in a Minority-Predominant CohortM Bakri Hammami, Jhannine Alyssa Verceles, Mendel Goldfinger, et al.
Annals of Internal Medicine|October 3, 2012
Inviting patients to read their doctors' notes: a quasi-experimental study and a look aheadTom Delbanco, Jan Walker, Sigall K Bell, et al.
Pageof 93

Showing results (821-830 of 921) with videos related to

Sort By:
Pageof 93
Leukemia Research|August 19, 2003
Phase II study of troxacitabine, a novel dioxolane nucleoside analog, in patients with untreated or imatinib mesylate-resistant chronic myelogenous leukemia in blastic phaseFrancis J Giles, Eric J Feldman, Gail J Roboz, et al.
JID Innovations : Skin Science From Molecules to Population Health|February 13, 2025
Exploring Pruritus in Bullous Pemphigoid: Analysis of QOL Metrics and Potential Biological MechanismsOlive C Osuoji, Taryn DeGrazia, Robin Rolader, et al.
Anatomical Sciences Education|January 9, 2023
Needs assessment of essential anatomy: The perspective of adult primary care resident physiciansMark H Hankin, Derek J Harmon, James R Martindale, et al.
Journal of Neurointerventional Surgery|February 9, 2021
Association of asymptomatic hemorrhage after endovascular stroke treatment with outcomesMichael J Feldman, Steven Roth, Matthew R Fusco, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2006
Phase I/II study of continuous-infusion troxacitabine in refractory acute myeloid leukemiaGail J Roboz, Francis J Giles, Ellen K Ritchie, et al.
Cancer Chemotherapy and Pharmacology|August 17, 2013
Clinical and laboratory studies of the novel cyclin-dependent kinase inhibitor dinaciclib (SCH 727965) in acute leukemiasIvana Gojo, Mariola Sadowska, Alison Walker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2006
Phase I study of bryostatin 1 and fludarabine in patients with chronic lymphocytic leukemia and indolent (non-Hodgkin's) lymphomaJohn D Roberts, Mitchell R Smith, Eric J Feldman, et al.
Inflammatory Bowel Diseases|May 19, 2015
Combined Immunosuppression Impairs Immunogenicity to Tetanus and Pertussis Vaccination Among Patients with Inflammatory Bowel DiseaseSeper Dezfoli, Henry A Horton, Nattapaun Thepyasuwan, et al.
Transplantation and Cellular Therapy|February 28, 2024
Improving Unrelated Donor Equity: Assessing Mismatched Donor Opportunities with Real-World Data in a Minority-Predominant CohortM Bakri Hammami, Jhannine Alyssa Verceles, Mendel Goldfinger, et al.
Annals of Internal Medicine|October 3, 2012
Inviting patients to read their doctors' notes: a quasi-experimental study and a look aheadTom Delbanco, Jan Walker, Sigall K Bell, et al.
Pageof 93